InsiderTrades

Form 4 for CYTK CYTOKINETICS INC

Accepted 2021-11-09 00:00:00 ET · period of report 2021-11-09 · accession 0001061983-21-000255 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-11-09 2021-11-09 CYTK Cragg David Chief HR, Admin Off S - Sale+OE $41.76 -45.0K 138.7K -24% -$1.88M
DM 2021-11-09 2021-11-09 CYTK Cragg David Chief HR, Admin Off M - OptEx $9.65 +45.0K 163.2K +38% +$434.2K
DM 2021-11-09 2021-11-09 CYTK Cragg David Chief HR, Admin Off M - OptEx $0.00 -45.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-09 S D 20,481 $41.76 138,704 D — — (F1) Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
2 Common Common Stock 2021-11-09 M A 20,481 $9.65 159,185 D — — (F1) Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
3 Common Common Stock 2021-11-09 S D 24,519 $41.76 138,704 D — — (F1) Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
4 Common Common Stock 2021-11-09 M A 24,519 $9.65 163,223 D — — (F1) Includes up to 13,678 shares of common stock purchased pursuant to the Cytokinetics, Incorporated Employee Stock Purchase Plan.
5 Derivative Incentive Stock Option (right to buy) 2021-11-09 M D 20,481 $0.00 0 D $9.65 · 2014-03-24 to 2024-02-24 20,481 Common Stock
6 Derivative Non-Qualified Stock Option (right to buy) 2021-11-09 M D 24,519 $0.00 0 D $9.65 · 2014-03-24 to 2024-02-24 24,519 Common Stock